Dendritic cells cancer immunotherapy for melanoma improved immunity index

This is a treatment result comparison between two groups of patients.

The value of CD3+, CD3+CD4+, CD4+/CD8+ and NK (Natural Killer) cells in peripheral blood significantly increased after a combination treatment including dendritic cells immunotherapy (DC therapy), comparing with patients who did not have DC therapy.

At the meanwhile, the value of IL-2, IL-12 and IFN-γin patient’s serum also increased.

Please look at below chart for detail.

Melanoma

 

 

Share this article

Effective and affordable immunotherapy and CAR T-cell Therapy?

Contact us and get detailed information about getting advanced immunotherapy and CAR T-cell therapy for the treatment of solid tumors, blood cancers and HPV infection.